Business refers to the organized effort of individuals or entities to provide goods and services to consumers in exchange for profit. It encompasses a broad range of activities, including the production, sale, and distribution of products, as well as the provision of services. Businesses can take various forms, such as sole proprietorships, partnerships, corporations, and cooperatives. The primary goal of a business is to generate revenue and achieve profitability, but it can also focus on factors like customer satisfaction, innovation, and social impact. The activities involved in business typically include market research, marketing, sales, finance, human resources, and operations. Overall, business plays a crucial role in the economy by creating jobs, driving innovation, and contributing to the overall wealth and growth of communities and nations.
A pivotal leadership change occurs at Edesa Biotech as Peter J. Weiler is appointed CFO, bringing extensive experience in business development and pharmaceutical leadership. Weiler's background includes key roles at…
Peter J. Weiler joins Edesa Biotech as CFO on May 1, 2025, bringing extensive leadership in biotechnology and pharmaceuticals. Weiler's experience includes roles as President of Exzell Pharma and VP…
Edesa Biotech appoints Peter J. Weiler as the new CFO, effective May 1, 2025, signaling a strategic shift. Weiler brings a robust track record in biotech and pharma, previously leading…
Edesa Biotech appoints Peter J. Weiler as the new Chief Financial Officer, effective May 2025, succeeding Stephen Lemieux. Weiler brings extensive experience in corporate finance and strategic development from Exzell…
The appointment of Peter J. Weiler as CFO marks a strategic shift for Edesa Biotech, effective May 1, 2025. Weiler brings extensive experience from roles at Exzell Pharma, Biosyent Inc.,…
Edesa Biotech has appointed Peter J. Weiler as its new Chief Financial Officer, effective May 1, 2025. Weiler brings extensive experience from leadership roles at Exzell Pharma, Biosyent Inc., and…
F-star Therapeutics has transitioned to an independent entity, reclaiming its narrative after separating from former acquirer invoX Pharma. The U.K.-based company is focused on advancing its innovative bispecific antibody platform,…
Jill Angelo transitions from Unified Women’s Healthcare, leaving a legacy in menopause health awareness and telehealth services with Gennev. Aurion Biotech advances in cell therapies for eye diseases, bolstered by…
Biotechnology innovation drives new therapies, with small and mid-size pharma firms playing a key role despite the challenges posed by larger companies and complex regulations. The global biotechnology market is…
Ajooni Biotech Limited reported a total income of 2,603.40 lakhs for Q4 2024, showcasing operational excellence. The company achieved a net profit of 73.02 lakhs, reflecting strategic foresight and efficient…